Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial

Han, Eugene; Huh, Ji Hye; Lee, Eun Y.; Bae, Ji C.; Chun, Sung W.; Yu, Sung H.; Kwak, Soo H.; Park, Kyong S.; Lee, Byung Wan

doi:10.1111/dom.14623

YUHSpace

BROWSE

0 708

Cited 0 times in

Cited 8 times in

Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial

Authors: Han, Eugene ; Huh, Ji Hye ; Lee, Eun Y. ; Bae, Ji C. ; Chun, Sung W. ; Yu, Sung H. ; Kwak, Soo H. ; Park, Kyong S. ; Lee, Byung Wan

Citation: Diabetes, Obesity and Metabolism, Vol.24(4) : 752-756, 2022-04

Journal Title: DIABETES OBESITY & METABOLISM

ISSN: 1462-8902

Issue Date: 2022-04

Keywords: dipeptidyl peptidase-4 inhibitor ; evogliptin ; magnetic resonance imaging-derived proton density fat fraction ; non-alcoholic fatty liver disease ; pioglitazone ; type 2 diabetes

Abstract: [No abstract available]

DOI: 10.1111/dom.14623

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

Yonsei Authors: Lee, Byung Wan(이병완) https://orcid.org/0000-0002-9899-4992

URI: https://ir.ymlib.yonsei.ac.kr/handle/22282913/188336

사서에게 알리기

Show full item record Find it @ YMLIB

License

YUHSpace: Efficacy and safety of evogliptin in patients with type 2 diabetes and non-alcoholic fatty liver disease: A multicentre, double-blind, randomized, comparative trial

YUHSpace

BROWSE

Browse

Links